Deltaretrovirus infections are primarily associated with the Human T-Cell Lymphotropic Virus (HTLV), a group of retroviruses that predominantly infect T lymphocytes. HTLV is divided into subtypes, with HTLV-1 and HTLV-2 being the most clinically significant. HTLV-1 is linked to various diseases, including Adult T-Cell Leukemia/Lymphoma (ATLL) and a progressive neurological disorder known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Infection occurs through contact with contaminated blood, sexual transmission, and from mother to child through breastfeeding. While the majority of individuals infected with HTLV-1 remain asymptomatic carriers, a subset develops severe complications. Diagnosis involves serological testing and molecular assays. There is no specific antiviral treatment for HTLV-1, and management focuses on treating associated conditions. Prevention strategies include promoting safe sexual practices, avoiding sharing of needles, and discouraging breastfeeding in infected mothers to reduce transmission risk.
Title : The role of the humoral innate immune system in evasion of streptococcus pyogenes infections
Francis J. Castellino, University of Notre Dame, United States
Title : Global environmental changes and mosquito-borne diseases in coastal areas
Ranjan Ramasamy, IDFISH Technology, United States
Title : The impact of global antibiotic resistance on the healthcare system, public health, environment and society
Reza Nassiri, Michigan State University, United States
Title : Current topics of adult COVID-19, Influenza, and RS virus patients in Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan
Title : Novel nanotechnology and its potential applications
Stephen Hsu, Augusta University, United States
Title : 2000 years of pandemics: Past, present and future
Claudia Ferreira, Biophytis Sorbonne, France